Aktie A2QPFX MAXCYTE, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen MaxCyte, Inc. London S.E.

Aktien

A2QPFX

USU575801258

MXCN

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
MaxCyte, Inc. - Publication of Annual Report
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO and CDMO services
MaxCyte, Inc. - Grant of Options and Restricted Stock Units
MaxCyte, Inc. - Results of AGM
MaxCyte, Inc. - PDMR Dealing
MaxCyte CEO Maher Masoud buys 100,000 shares
Maxcyte Insider Bought Shares Worth $489,066, According to a Recent SEC Filing
MaxCyte : Participation in Upcoming Investor Conference
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
MaxCyte inks deal with Legend Biotech for tech supply
MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
MaxCyte, Inc. Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
MaxCyte announces filing of Form 10-Q for the quarterly period ended March 31, 2024
MaxCyte Shares Rise Sharply After Q1 Results Beat
MaxCyte shares rise amid double-digit revenue increase
Earnings Flash (MXCT.L) MAXCYTE Posts Q1 Revenue $11.3M
Earnings Flash (MXCT.L) MAXCYTE Reports Q1 Loss $-0.09
MaxCyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2AGVE Aktie
  4. A2QPFX Aktie
  5. Nachrichten MaxCyte, Inc.
  6. Andere Sprachen